UNION KOREA PHARM Calls Extraordinary General Meeting to Replace Entire Board Under Rehabilitation Plan
UNION KOREA PHARM, with court approval, will hold an extraordinary general meeting on July 21, 2026 with record date July 3, 2026.
The agenda includes the election of four new directors and removal of seven current directors, a complete board overhaul. Candidates include Seong Gwang-hyeon and Kim Seong-su as inside directors, and Im Jeong-su and Min Byeong-hwan as outside directors.
This move is part of the court-led rehabilitation plan, with key nominees from Bugwang Pharm, raising potential governance conflicts and shareholder value dilution concerns.
[AI Summary]UNION KOREA PHARM is executing a full management replacement via an extraordinary general meeting during rehabilitation. While short-term uncertainty is high, the new directors' expertise may improve long-term recovery prospects. Shareholder value around the current market cap of 216 billion KRW depends on successful plan execution.
KOSDAQ Filing Information
[Correction of Description] Resolution on Convening of General Meeting of Shareholders (Extraordinary General Meeting)